• Home
  • Agric
  • Sci & Tech
  • Health
  • Environment
  • Hausa News
  • More
    • Business/Banking & Finance
    • POLITICS
    • Entertainments & Sports
    • International
    • Investigation
    • Law & Human Rights
    • Africa
    • ACCOUNTABILITY/CORRUPTION
    • Hassan Gimba
    • Column
    • Prof. Jibrin Ibrahim
    • Prof. M.K. Othman
    • Defense/Security
    • Education
    • Energy/Electricity
    • Entertainment/Arts & Sports
    • Society and Lifestyle
    • Food & Agriculture
    • Health & Healthy Living
    • International News
    • Interviews
    • Investigation/Fact-Check
    • LAW & HUMAN RIGHTS
    • Oil & Gas/Mineral Resources
    • PRESS FREEDOM/JOURNALISM/PR
    • General News
    • Presidency
  • About Us
    • Contact Us
    • Board Of Advisory
    • Privacy Policy
    • Ethics Policy
    • Teamwork And Collaboration Policy
    • Fact-Checking Policy
    • Advertising
  • Media OutReach Newswire
    • Wire News
  • The Stories
Facebook Twitter Instagram
Trending
  • NCDC taps PR networks to deepen communication of development agenda
  • Nigeria’s 2026 wet season harvest shows modest growth
  • CJID announces 2026 media, development conference
  • ANPA calls for sustainable diaspora health partnerships
  • AFAN: Guarantee minimum prices to protect farmers
  • CBN clears Milestone Global Bank for regional non-interest operations
  • CAPRIGHTS-VP warns against child domestic servitude
  • NDLEA urges research to tackle emerging addiction risks
Facebook Twitter Instagram YouTube
AsheNewsAsheNews
  • Home
  • Agric

    Nigeria’s 2026 wet season harvest shows modest growth

    November 18, 2026

    AFAN: Guarantee minimum prices to protect farmers

    November 18, 2026

    NAERLS warns of flood, pest risks to food security

    November 18, 2026

    AFAN applauds fertiliser support ahead of dry season

    November 18, 2026

    Agriculture show opens with call for food system reform

    November 18, 2026
  • Sci & Tech

    CJID announces 2026 media, development conference

    November 18, 2026

    GOVMAIL adoption grows across Nigeria’s public sector

    November 17, 2026

    CADEF: Low public trust threatens Nigeria’s energy transition

    November 14, 2026

    Nigeria plans satellite facility in Epe

    November 12, 2026

    3MTT seeks partners to train Nigerians in digital skills

    November 12, 2026
  • Health

    ANPA calls for sustainable diaspora health partnerships

    November 18, 2026

    CAPRIGHTS-VP warns against child domestic servitude

    November 18, 2026

    NDLEA urges research to tackle emerging addiction risks

    November 18, 2026

    DUFUHS equips teaching hospital with N450m in medical supplies

    November 18, 2026

    NELCCI takes HIV, TB, Malaria awareness to Enugu school

    November 18, 2026
  • Environment

    Partnership targets open defecation in 8 states

    November 18, 2026

    Air Peace adds more daily flights between Lagos, Abuja

    November 18, 2026

    Earthshot prize awards £1m to 5 green initiatives

    November 18, 2026

    Gombe plans to turn faecal waste into fertiliser

    November 17, 2026

    HOMEF, Oilwatch urge community-led just transition

    November 15, 2026
  • Hausa News

    Foundation unveils public sector reform playbook

    November 12, 2026

    Tinubu asks Reps to approve N10.79tn external borrowing for 2026 budget

    November 11, 2026

    UNA signs MoU to launch air Bissau in Guinea-Bissau

    June 15, 2026

    Otti plans 250-room 5-star hotel in Umuahia

    April 11, 2026

    Anti-quackery task force seals 4 fake hospitals in Rivers

    August 29, 2025
  • More
    1. Business/Banking & Finance
    2. POLITICS
    3. Entertainments & Sports
    4. International
    5. Investigation
    6. Law & Human Rights
    7. Africa
    8. ACCOUNTABILITY/CORRUPTION
    9. Hassan Gimba
    10. Column
    11. Prof. Jibrin Ibrahim
    12. Prof. M.K. Othman
    13. Defense/Security
    14. Education
    15. Energy/Electricity
    16. Entertainment/Arts & Sports
    17. Society and Lifestyle
    18. Food & Agriculture
    19. Health & Healthy Living
    20. International News
    21. Interviews
    22. Investigation/Fact-Check
    23. LAW & HUMAN RIGHTS
    24. Oil & Gas/Mineral Resources
    25. PRESS FREEDOM/JOURNALISM/PR
    26. General News
    27. Presidency
    Featured
    Recent

    NCDC taps PR networks to deepen communication of development agenda

    November 18, 2026

    Nigeria’s 2026 wet season harvest shows modest growth

    November 18, 2026

    CJID announces 2026 media, development conference

    November 18, 2026
  • About Us
    1. Contact Us
    2. Board Of Advisory
    3. Privacy Policy
    4. Ethics Policy
    5. Teamwork And Collaboration Policy
    6. Fact-Checking Policy
    7. Advertising
    Featured
    Recent

    NCDC taps PR networks to deepen communication of development agenda

    November 18, 2026

    Nigeria’s 2026 wet season harvest shows modest growth

    November 18, 2026

    CJID announces 2026 media, development conference

    November 18, 2026
  • Media OutReach Newswire
    • Wire News
  • The Stories
AsheNewsAsheNews
Home»General News»COVID-19: S. Korea OKs Celltrion’s treatment for conditional use
General News

COVID-19: S. Korea OKs Celltrion’s treatment for conditional use

EditorBy EditorFebruary 5, 2021No Comments2 Mins Read
Share
Facebook Twitter LinkedIn Pinterest Email

South Korea’s drug safety agency said Friday it has approved pharmaceutical giant Celltrion Inc.’s COVID-19 treatment candidate on several conditions.

Yonhap reports that the Korean Ministry of Food and Drug Safety, said CT-P59 can be administered to COVID-19 patients at higher risk.

This approval refers to people aged 60 or older, or with health conditions like heart disease, diabetes, high pressure or chronic diseases that affect the respiratory system.

The ministry also announced the authorization on the condition that Celltrion submit results of the global phase-three clinical trial.

Last month, Celltrion announced top-line results from its randomized and placebo controlled global phase-two clinical study, saying CT-P59 reduces recovery time and the chance of a severe case.

Celltrion plans to conduct a global phase-three clinical trial, a pivotal part of the study, in more than 10 countries to obtain more comprehensive safety and efficacy results of CT-P59.

The company also plans to submit an application for Emergency Use Authorization (EUA) with the U.S. Food and Drug Administration and for Conditional Marketing Authorization to the European Medicines Agency (EMA) in the coming months.

CT-P59 takes the form of an intravenous injection that is directly injected into the vein for 90 minutes.

With reports by Yonhap

Celltrion COVID-19 South Korea treatment
Share. Facebook Twitter Pinterest LinkedIn WhatsApp Reddit Tumblr Email
Editor
  • Website

Related Posts

NCDC taps PR networks to deepen communication of development agenda

November 18, 2026

ANPA calls for sustainable diaspora health partnerships

November 18, 2026

CAPRIGHTS-VP warns against child domestic servitude

November 18, 2026

Leave A Reply Cancel Reply

NCDC taps PR networks to deepen communication of development agenda

November 18, 2026

Nigeria’s 2026 wet season harvest shows modest growth

November 18, 2026

CJID announces 2026 media, development conference

November 18, 2026

ANPA calls for sustainable diaspora health partnerships

November 18, 2026
About Us
About Us

ASHENEWS (AsheNewsDaily.com), published by PenPlus Online Media Publishers, is an independent online newspaper. We report development news, especially on Agriculture, Science, Health and Environment as they affect the under-reported rural and urban poor.

We also conduct investigations, especially in the areas of ASHE, as well as other general interests, including corruption, human rights, illicit financial flows, and politics.

Contact Info:
  • 1st floor, Dogon Daji House, No. 5, Maiduguri Road, Sokoto
  • +234(0)7031140009
  • ashenewsdaily@gmail.com
Facebook Twitter Instagram Pinterest
© 2026 All Rights Reserved. ASHENEWS Daily Designed & Managed By DeedsTech

Type above and press Enter to search. Press Esc to cancel.